A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds

J.N. Sleigh, S.D. Buckingham, B. Esmaelli, M. Viswanathan, E.P.J.G. Cuppen, B.M. Westlund, D.B. Sattelle

Research output: Contribution to journalArticleAcademicpeer-review

Cite this